Literature DB >> 1792634

Cystic fibrosis: current survival and population estimates to the year 2000.

J S Elborn1, D J Shale, J R Britton.   

Abstract

BACKGROUND: Survival from cystic fibrosis is increasing rapidly. Estimates of the extent of this improvement should allow health care facilities to be planned to deal with the expanding population of patients with cystic fibrosis. Estimates of life expectancy are also essential if accurate information on current prognosis is to be given to parents of an affected child, or to prospective parents deciding whether to proceed with a pregnancy where the fetus may be affected.
METHODS: Survival trends in the national data on cystic fibrosis have been analysed to produce estimates of the likely size of the cystic fibrosis population over the next decade and to predict the life expectancy of children born with cystic fibrosis in the years up to 1990.
RESULTS: In England and Wales the estimated number of patients with cystic fibrosis is at present about 5200, of whom 3300 (63%) are aged under 16 years. By the year 2000 the total population will increase to 6000, with 3400 (57%) aged under 16. Thus the number of children with cystic fibrosis will remain fairly constant over the next 10 years, whereas adult numbers will increase by about 36% (from 1901 to 2577). The median life expectancy of children with cystic fibrosis born in 1990 is estimated to be 40 years, double that of 20 years ago.
CONCLUSION: This study suggests that health service provision for children will not need to change substantially over the next 10 years whereas services for adults will need to increase by about a third. Parents can be counselled that the median life expectancy of a newborn child with cystic fibrosis is currently likely to be of the order of 40 years.

Entities:  

Mesh:

Year:  1991        PMID: 1792634      PMCID: PMC463492          DOI: 10.1136/thx.46.12.881

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  12 in total

Review 1.  Identification of the cystic fibrosis gene.

Authors:  R A Knight; M E Hodson
Journal:  BMJ       Date:  1990-02-10

2.  Survival patterns in cyctic fibrosis.

Authors:  W J Warwick; R E Pogue; H U Gerber; C J Nesbitt
Journal:  J Chronic Dis       Date:  1975-12

3.  Screening for cystic fibrosis; public policy and personal choices.

Authors:  H R Colten
Journal:  N Engl J Med       Date:  1990-02-01       Impact factor: 91.245

4.  Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis.

Authors:  W K Lemna; G L Feldman; B Kerem; S D Fernbach; E P Zevkovich; W E O'Brien; J R Riordan; F S Collins; L C Tsui; A L Beaudet
Journal:  N Engl J Med       Date:  1990-02-01       Impact factor: 91.245

5.  Carrier screening for cystic fibrosis.

Authors:  L P Ten Kate; T Tijmstra
Journal:  Lancet       Date:  1989-10-21       Impact factor: 79.321

6.  Survival of patients with cystic fibrosis.

Authors:  N N Huang; C N Macri; J Girone; A Sproul
Journal:  Am J Dis Child       Date:  1970-10

7.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

8.  A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto.

Authors:  M Corey; F J McLaughlin; M Williams; H Levison
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

9.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

10.  Cystic fibrosis in the United Kingdom 1977-85: an improving picture. British Paediatric Association Working Party on Cystic Fibrosis.

Authors: 
Journal:  BMJ       Date:  1988-12-17
View more
  74 in total

1.  The adaptations of a quality of life questionnaire for routine use in clinical practice: the Chronic Respiratory Disease Questionnaire in cystic fibrosis.

Authors:  J Bradley; M Dempster; E Wallace; S Elborn
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

Review 2.  New therapeutic approaches for cystic fibrosis lung disease.

Authors:  Jane C Davies
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

3.  The cost of care in cystic fibrosis.

Authors:  D J Shale
Journal:  Thorax       Date:  1992-09       Impact factor: 9.139

4.  Cystic fibrosis: current survival and population estimates to the year 2000.

Authors:  D P Addy
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

Review 5.  How a clinical psychologist manages the problems of adults with cystic fibrosis.

Authors:  Helen Oxley; A K Webb
Journal:  J R Soc Med       Date:  2005       Impact factor: 5.344

6.  Pulmonary exacerbations in cystic fibrosis and bronchiectasis.

Authors:  J S Elborn; S C Bell
Journal:  Thorax       Date:  2007-04       Impact factor: 9.139

7.  Production and characterization of a set of mouse-human chimeric immunoglobulin G (IgG) subclass and IgA monoclonal antibodies with identical variable regions specific for Pseudomonas aeruginosa serogroup O6 lipopolysaccharide.

Authors:  M J Preston; A A Gerçeker; M E Reff; G B Pier
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Glucose tolerance in patients with cystic fibrosis: five year prospective study.

Authors:  S Lanng; A Hansen; B Thorsteinsson; J Nerup; C Koch
Journal:  BMJ       Date:  1995-09-09

9.  Outcome of pregnancy in women with cystic fibrosis.

Authors:  F P Edenborough; D E Stableforth; A K Webb; W E Mackenzie; D L Smith
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

10.  Comfort of general internists and general pediatricians in providing care for young adults with chronic illnesses of childhood.

Authors:  Megumi J Okumura; Michele Heisler; Matthew M Davis; Michael D Cabana; Sonya Demonner; Eve A Kerr
Journal:  J Gen Intern Med       Date:  2008-07-26       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.